Back to BlackRock, Inc. BlackRock, Inc.

CADLCADL
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in CANDEL THERAPEUTICS INC

BlackRock, Inc. holds 5M shares of CADL (CANDEL THERAPEUTICS INC), worth $51.2M as of 2026-Q2. The position was increased (+59.8% shares). CADL represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$51.2M

Current Shares

5M

Total Value Change

+$40.9M

Total Shares Change

+3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5M
+59.8%
$51.2M0.0%$10.30
42
2026-Q1
Increased
3.1M
+8.6%
$15.2M0.0%$4.91
31
2025-Q4
Increased
2.9M
+20.3%
$16.2M0.0%$5.71
34
2025-Q3
Increased
2.4M
+3.4%
$12.1M0.0%$5.40
29
2025-Q2
Increased
2.3M
+30.5%
$11.6M0.0%$4.90
35
2025-Q1
Increased
1.8M
+49.0%
$10M0.0%$5.95
38
2024-Q4
New
1.2M
-
$10.3M0.0%$7.95
38

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used